Table 1. Patient demographics and stricture details.
| Variables | Values |
|---|---|
| Age (years) | 60.1±17.1 |
| Male | 43 |
| Ethnicity | |
| Caucasian | 38 (88.4) |
| Black | 3 (7.0) |
| Asian | 1 (2.3) |
| Hispanic | 1 (2.3) |
| Urethral stricture disease treatment prior to DCB | |
| None | 16 (37.2) |
| Endoscopic management only | 16 (37.2) |
| Urethroplasty and endoscopic management | 11 (25.6) |
| Stricture location | |
| Bulbar urethra | 17 (39.5) |
| Pendulous urethra | 7 (16.3) |
| Membranous urethra | 7 (16.3) |
| Bladder neck | 7 (16.3) |
| Prostatic urethra | 3 (7.0) |
| Fossa navicularis | 2 (4.7) |
The data are presented as the average ± standard deviation, or the number of participants with their affiliated percentage in the total cohort. DCB, Optilume Urethral Drug Coated Balloon.